Sign In
Buy WGS
$53.02
-0.110 (-0.207%)
At Close: Jun 03, 2026
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
04:05pm, Monday, 13'th Apr 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced it will release financial results for the first quarter of 2026 after the market closes on Monday, May 4, 2026.
Three Best Genomics Stocks for Your Portfolio in 2026
11:20am, Monday, 13'th Apr 2026
Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11:32am, Wednesday, 08'th Apr 2026
Robinhood Markets is coming off its weakest top-line growth in two years, and the next few quarters could be worse. GeneDX is the hardest hit stock on this list this year, but it has still bucked the
Q Biomed (OTCMKTS:QBIO) vs. GeneDx (NASDAQ:WGS) Financial Comparison
01:35am, Sunday, 05'th Apr 2026
GeneDx (NASDAQ: WGS - Get Free Report) and Q Biomed (OTCMKTS:QBIO - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the streng
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 46,933 Shares of Stock
05:00am, Friday, 03'rd Apr 2026
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) CEO Katherine Stueland sold 46,933 shares of GeneDx stock in a transaction on Thursday, March 26th. The stock was sold at an average price of $63.
New Strong Buy Stocks for April 2nd
07:16am, Thursday, 02'nd Apr 2026
DNUT, GCT, WGS, VSNT and FLOC have been added to the Zacks Rank #1 (Strong Buy) List on April 2nd, 2026.
Assenagon Asset Management S.A. Has $26.78 Million Stake in GeneDx Holdings Corp. $WGS
03:04am, Thursday, 26'th Mar 2026
Assenagon Asset Management S.A. boosted its holdings in shares of GeneDx Holdings Corp. (NASDAQ: WGS) by 1,358.7% in the fourth quarter, according to its most recent filing with the Securities and Exc
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know
01:01pm, Tuesday, 24'th Mar 2026
GENEDX HOLDINGS (WGS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for March 18th
06:55am, Wednesday, 18'th Mar 2026
NWPX, INNV, WGS, BCBP and BWXT have been added to the Zacks Rank #1 (Strong Buy) List on March 18, 2026.
Financial Contrast: GeneDx (NASDAQ:WGS) & Amarantus Bioscience (OTCMKTS:AMBS)
01:42am, Sunday, 15'th Mar 2026
GeneDx (NASDAQ: WGS - Get Free Report) and Amarantus Bioscience (OTCMKTS:AMBS - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses ba
100,284 Shares in GeneDx Holdings Corp. $WGS Bought by Capital International Investors
04:08am, Friday, 13'th Mar 2026
Capital International Investors acquired a new position in GeneDx Holdings Corp. (NASDAQ: WGS) during the undefined quarter, according to the company in its most recent filing with the Securities and
Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?
11:07am, Thursday, 12'th Mar 2026
Cathie Wood and Ark Invest have been snatching up shares of a small cap diagnostics company for seven straight days. Here's the stock.
GeneDx Holdings Corp. (WGS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
05:22pm, Wednesday, 11'th Mar 2026
GeneDx Holdings Corp. (WGS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
GAITHERSBURG, Md.--(BUSINESS WIRE)--Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing.
WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type C
01:56pm, Wednesday, 11'th Mar 2026
GeneDx launches Zevra-backed testing program to expand ExomeDx access for Niemann-Pick Type C, aiming to speed diagnosis and add data to its Infinity dataset.
